78 related articles for article (PubMed ID: 24483192)
21. Intraarterial Therapy Using Micellar Nanoparticles Incorporating SN-38 in a Rabbit Liver Tumor Model.
Nishiofuku H; Tanaka T; Fukuoka Y; Sato T; Masada T; Tatsumoto S; Sho M; Yamato I; Yasuda S; Matsushima S; Takano M; Ohbayashi C; Kichikawa K
J Vasc Interv Radiol; 2017 Mar; 28(3):457-464. PubMed ID: 28041782
[TBL] [Abstract][Full Text] [Related]
22. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.
Jun YJ; Jadhav VB; Min JH; Cui JX; Chae SW; Choi JM; Kim IS; Choi SJ; Lee HJ; Sohn YS
Int J Pharm; 2012 Jan; 422(1-2):374-80. PubMed ID: 22079718
[TBL] [Abstract][Full Text] [Related]
23. The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.
LaBonte MJ; Manegold PC; Wilson PM; Fazzone W; Louie SG; Lenz HJ; Ladner RD
Int J Cancer; 2009 Dec; 125(12):2957-69. PubMed ID: 19536776
[TBL] [Abstract][Full Text] [Related]
24. [CPT-11 hepatic arterial infusion chemotherapy for metastatic liver tumor from gastric cancer].
Nagahama T; Ando M; Maruyama M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1822-4. PubMed ID: 15553727
[TBL] [Abstract][Full Text] [Related]
25. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
[TBL] [Abstract][Full Text] [Related]
26. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
27. Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.
Minelli R; Cavalli R; Ellis L; Pettazzoni P; Trotta F; Ciamporcero E; Barrera G; Fantozzi R; Dianzani C; Pili R
Eur J Pharm Sci; 2012 Nov; 47(4):686-94. PubMed ID: 22917641
[TBL] [Abstract][Full Text] [Related]
28. Preparation and antitumor study of camptothecin nanocrystals.
Zhang H; Hollis CP; Zhang Q; Li T
Int J Pharm; 2011 Aug; 415(1-2):293-300. PubMed ID: 21679755
[TBL] [Abstract][Full Text] [Related]
29. [Chemotherapy by combination of low-dose CPT-11 and PSK in an elderly man with liver metastasis from gastric cancer].
Takahashi Y; Mai M
Gan To Kagaku Ryoho; 2001 Apr; 28(4):531-4. PubMed ID: 11329790
[TBL] [Abstract][Full Text] [Related]
30. Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.
Kumazawa E; Jimbo T; Ochi Y; Tohgo A
Cancer Chemother Pharmacol; 1998; 42(3):210-20. PubMed ID: 9685056
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of new orthotopic and metastatic neuroblastoma models.
Daudigeos-Dubus E; LE Dret L; Rouffiac V; Bawa O; Leguerney I; Opolon P; Vassal G; Geoerger B
In Vivo; 2014; 28(4):425-34. PubMed ID: 24982206
[TBL] [Abstract][Full Text] [Related]
32. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
[TBL] [Abstract][Full Text] [Related]
33. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles.
Kawano K; Watanabe M; Yamamoto T; Yokoyama M; Opanasopit P; Okano T; Maitani Y
J Control Release; 2006 May; 112(3):329-32. PubMed ID: 16678929
[TBL] [Abstract][Full Text] [Related]
34. Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.
Sapra P; Zhao H; Mehlig M; Malaby J; Kraft P; Longley C; Greenberger LM; Horak ID
Clin Cancer Res; 2008 Mar; 14(6):1888-96. PubMed ID: 18347192
[TBL] [Abstract][Full Text] [Related]
35. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer.
Yao M; Zhou W; Sangha S; Albert A; Chang AJ; Liu TC; Wolfe MM
Clin Cancer Res; 2005 Feb; 11(4):1618-28. PubMed ID: 15746067
[TBL] [Abstract][Full Text] [Related]
36. Poly (amino acid) micelle nanocarriers in preclinical and clinical studies.
Matsumura Y
Adv Drug Deliv Rev; 2008 May; 60(8):899-914. PubMed ID: 18406004
[TBL] [Abstract][Full Text] [Related]
37. Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis.
Rafi M; Cabral H; Kano MR; Mi P; Iwata C; Yashiro M; Hirakawa K; Miyazono K; Nishiyama N; Kataoka K
J Control Release; 2012 Apr; 159(2):189-96. PubMed ID: 22326402
[TBL] [Abstract][Full Text] [Related]
38. [Experimental study on intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis].
Maruyama M; Nagahama T; Ebuchi M; Yuasa Y
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1855-7. PubMed ID: 11086429
[TBL] [Abstract][Full Text] [Related]
39. Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer.
Gaur S; Chen L; Yen T; Wang Y; Zhou B; Davis M; Yen Y
Nanomedicine; 2012 Jul; 8(5):721-30. PubMed ID: 22033079
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors.
Hamaguchi T; Doi T; Eguchi-Nakajima T; Kato K; Yamada Y; Shimada Y; Fuse N; Ohtsu A; Matsumoto S; Takanashi M; Matsumura Y
Clin Cancer Res; 2010 Oct; 16(20):5058-66. PubMed ID: 20943763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
